
Long-term study to inform gene therapy development
Genespire has commenced patient enrolment in an observational study, InforMMA, in children with methylmalonic acidemia (MMA) caused by mutations in the MMUT gene. The study is designed to follow patients aged up to 16 years who live with severe MMA, with the aim of better characterising disease… Read More
